[胃肠道间质瘤病理诊断与靶向治疗中的KIT突变分析：最新进展] - Suppr | 超能文献

[KIT mutation analysis in pathological diagnosis and target-therapy of gastrointestinal stromal tumors: an update].

作者信息

Chen Li-Rong

出版信息

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):440-3.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[KIT mutation analysis in pathological diagnosis and target-therapy of gastrointestinal stromal tumors: an update].[胃肠道间质瘤病理诊断与靶向治疗中的KIT突变分析：最新进展]

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):440-3.

2

[Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].[继发性伊马替尼耐药胃肠道间质瘤的分子与组织学特征]

Zhonghua Bing Li Xue Za Zhi. 2013 Jan;42(1):42-3. doi: 10.3760/cma.j.issn.0529-5807.2013.01.009.

3

A hemodialysis patient with primary extra-gastrointestinal stromal tumor: favorable outcome with imatinib mesylate.一名患有原发性胃肠道外间质瘤的血液透析患者：甲磺酸伊马替尼治疗效果良好。

Intern Med. 2012;51(12):1561-5. doi: 10.2169/internalmedicine.51.6709. Epub 2012 Jun 15.

4

[Consensus on the medical treatment of gastrointestinal stromal tumors].[胃肠间质瘤的医学治疗共识]

Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):875-7.

5

[Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].[胃肠道肿瘤的化疗与靶向治疗呼唤病理学的发展]

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):438-9.

6

Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.1型神经纤维瘤病相关的KIT和PDGFRA野生型胃肠道间质瘤对伊马替尼的反应

Dig Dis Sci. 2006 Jun;51(6):1043-6. doi: 10.1007/s10620-006-8003-1.

7

Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene.一名无法切除的十二指肠胃肠道间质瘤患者对甲磺酸伊马替尼产生继发性耐药，该患者c-kit原癌基因的第9、11、13或17外显子无突变。

J Gastroenterol. 2004 Sep;39(9):904-5. doi: 10.1007/s00535-003-1409-z.

8

[Chinese consensus in diagnosis and treatment of gastrointestinal stromal tumor].[中国胃肠间质瘤诊断与治疗共识]

Zhonghua Bing Li Xue Za Zhi. 2009 Oct;38(10):697-702.

9

Effect of imatinib mesylate in a patient with a metastatic gastrointestinal stromal tumor with a c-kit mutation in exon 11.甲磺酸伊马替尼对一名外显子11存在c-kit突变的转移性胃肠道间质瘤患者的疗效。

Dig Dis Sci. 2007 Jul;52(7):1725-9. doi: 10.1007/s10620-006-9092-6. Epub 2007 Feb 15.

10

[Gastrointestinal stromal tumor of small intestine associated with lymph node metastasis: a report of 2 cases with review of literatures].[小肠胃肠道间质瘤伴淋巴结转移：附2例报告并文献复习]

Zhonghua Bing Li Xue Za Zhi. 2009 Sep;38(9):617-20.